Judy Browning

1.2k total citations
18 papers, 925 citations indexed

About

Judy Browning is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Judy Browning has authored 18 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 10 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Judy Browning's work include Immunotherapy and Immune Responses (15 papers), vaccines and immunoinformatics approaches (6 papers) and RNA Interference and Gene Delivery (5 papers). Judy Browning is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), vaccines and immunoinformatics approaches (6 papers) and RNA Interference and Gene Delivery (5 papers). Judy Browning collaborates with scholars based in Australia, United States and Belgium. Judy Browning's co-authors include Jonathan Cebon, Ian D. Davis, Duncan MacGregor, Suzanne Svobodová, Sue Sturrock, Achim A. Jungbluth, Catherine Barrow, Weisan Chen, Craig Gedye and Lisa M. Ebert and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Judy Browning

18 papers receiving 908 citations

Peers

Countries citing papers authored by Judy Browning

Since Specialization

Citations

This map shows the geographic impact of Judy Browning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy Browning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy Browning more than expected).

Fields of papers citing papers by Judy Browning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy Browning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy Browning. The network helps show where Judy Browning may publish in the future.

Co-authorship network of co-authors of Judy Browning

This figure shows the co-authorship network connecting the top 25 collaborators of Judy Browning. A scholar is included among the top collaborators of Judy Browning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy Browning. Judy Browning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	ROS1 rearrangements in non-small cell lung cancer: screening by immunohistochemistry using proportion of cells staining without intensity and excluding cases with MAPK pathway drivers improves test performance 2021 ·Pathology ·Owen W.J. Prall, Judy Browning, (unknown), (unknown), (unknown), Chelsee Hewitt, (unknown), Gareth W. Lamb, (unknown), (unknown), (unknown), Shani Stuart, Huiling Xu, Andrew Fellowes, Stephen B. Fox	2
2	A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors 2020 ·Laboratory Investigation ·Christopher R. McEvoy, Holly Holliday, Niko Thio, Catherine Mitchell, (unknown), (unknown), (unknown), Huiling Xu, Stephen Lade, Judy Browning, Elena A. Takano, David J. Byrne, Anthony J. Gill, Cuong Duong, Jason Li, Andrew Fellowes, Stephen B. Fox, Alexander Swarbrick, Owen W.J. Prall	16
3	A Malignant Neoplasm From the Jejunum With a MALAT1-GLI1 Fusion and 26-Year Survival History 2020 ·International Journal of Surgical Pathology ·Owen W.J. Prall, Christopher R. McEvoy, David J. Byrne, Amir Iravani, Judy Browning, David Y.H. Choong, (unknown), (unknown), Kortnye Smith, Stephen J. Luen, Paul Mitchell, Jayesh Desai, Stephen B. Fox, Andrew Fellowes, Huiling Xu	30
4	A Pilot Study of Peripheral Blood BDCA-1 (CD1c) Positive Dendritic Cells Pulsed with NY-ESO-1 ISCOMATRIX™ Adjuvant 2017 ·Immunotherapy ·Ian D. Davis, (unknown), (unknown), (unknown), Tsin Yee Tai, Genevieve Whitty, (unknown), Lisa M. Ebert, Heather Jackson, Judy Browning, Duncan MacGregor, Frederick Wittke, Gregor Winkels, (unknown), Lena Miloradovic, Eugene Maraskovsky, Weisan Chen, Jonathan Cebon	14
5	NY‐ESO ‐1 specific antibody and cellular responses in melanoma patients primed with NY‐ESO ‐1 protein in ISCOMATRIX and boosted with recombinant NY‐ESO ‐1 fowlpox virus 2014 ·International Journal of Cancer ·Ji‐Li Chen, (unknown), Andrea Tarlton, Sacha Gnjatic, Abdelouahid Tajar, Ioannis Karydis, Judy Browning, Sarah Pratap, (unknown), Ralph Venhaus, Linda Pan, Douglas G. Altman, Jonathan Cebon, (unknown), Paul Nathan, Christian H. Ottensmeier, Mark R. Middleton, Vincenzo Cerundolo	40
6	Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma 2011 ·British Journal of Ophthalmology ·(unknown), (unknown), (unknown), Judy Browning, Claudia Freyer, Jonathan Cebon, Michele C. Madigan	20
7	Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™ 2011 ·Cancer Immunology Immunotherapy ·Theo Nicholaou, Weisan Chen, Ian D. Davis, Heather Jackson, Nektaria Dimopoulos, Catherine Barrow, Judy Browning, Duncan MacGregor, David Williams, Wendie Hopkins, Eugene Maraskovsky, Ralph Venhaus, Linda Pan, Eric W. Hoffman, Lloyd J. Old, Jonathan Cebon	35
8	Cancer–testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate 2010 ·European Journal of Cancer ·Suzanne Svobodová, Judy Browning, Duncan MacGregor, Gabriele Pollara, Richard A. Scolyer, Rajmohan Murali, John F. Thompson, Siddhartha Deb, Arun Azad, Ian D. Davis, Jonathan Cebon	44
9	Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells 2009 ·Cancer Immunology Immunotherapy ·Craig Gedye, (unknown), Judy Browning, Suzanne Svobodová, Thomas John, Pavel Sluka, P. Rod Dunbar, Denis Corbeil, Jonathan Cebon, Ian D. Davis	56
10	Melan-A–specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4 2009 ·Clinical Cancer Research ·Oliver Klein, Lisa M. Ebert, Theo Nicholaou, Judy Browning, Sarah E. Russell, (unknown), Heather Jackson, Nektaria Dimopoulos, Bee Shin Tan, Axel Hoos, Immanuel F. Luescher, Ian D. Davis, Weisan Chen, Jonathan Cebon	78
11	The Regulatory T Cell–Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells 2008 ·Cancer Research ·Lisa M. Ebert, Bee Shin Tan, Judy Browning, Suzanne Svobodová, Sarah E. Russell, (unknown), Craig Gedye, Denis J. Moss, Sweet Ping Ng, Duncan MacGregor, Ian D. Davis, Jonathan Cebon, Weisan Chen	152
12	Distinctive localization of antigen-presenting cells in human lymph nodes 2008 ·Blood ·Catherine E. Angel, Chun‐Jen J. Chen, (unknown), (unknown), Thomas John, Judy Browning, Duncan MacGregor, Jonathan Cebon, P. Rod Dunbar	72
13	ECSA/DPPA2 is an Embryo-Cancer Antigen that Is Coexpressed with Cancer-Testis Antigens in Non–Small Cell Lung Cancer 2008 ·Clinical Cancer Research ·Thomas John, Otávia L. Caballero, Suzanne Svobodová, (unknown), Ramon Chua, Judy Browning, Sheila R. Fortunato, Siddhartha Deb, Melinda Laine Hsu, Craig Gedye, Ian D. Davis, Nasser K. Altorki, Andrew J.G. Simpson, Yao‐Tseng Chen, Marilyn Monk, Jonathan Cebon	27
14	Striking Immunodominance Hierarchy of Naturally Occurring CD8+ and CD4+ T Cell Responses to Tumor Antigen NY-ESO-1 2006 ·The Journal of Immunology ·Heather Jackson, Nektaria Dimopoulos, Nicole A. Mifsud, Tsin Yee Tai, Qiyuan Chen, Suzanne Svobodová, Judy Browning, Immanuel F. Luescher, (unknown), Lloyd J. Old, Ian D. Davis, Jonathan Cebon, Weisan Chen	32
15	Blood Dendritic Cells Generated With Flt3 Ligand and CD40 Ligand Prime CD8+ T Cells Efficiently in Cancer Patients 2006 ·Journal of Immunotherapy ·Ian D. Davis, Qiyuan Chen, (unknown), (unknown), (unknown), (unknown), Phillip Parente, (unknown), Wendie Hopkins, Heather Jackson, Nektaria Dimopoulos, Tsin Yee Tai, Duncan MacGregor, Judy Browning, Suzanne Svobodová, Dania Caron, Eugene Maraskovsky, Lloyd J. Old, Weisan Chen, Jonathan Cebon	57
16	Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens 2006 ·Melanoma Research ·Elgene Lim, Judy Browning, Duncan MacGregor, Ian D. Davis, Jonathan Cebon	13
17	Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage 2006 ·Clinical Cancer Research ·Catherine Barrow, Judy Browning, Duncan MacGregor, Ian D. Davis, Sue Sturrock, Achim A. Jungbluth, Jonathan Cebon	186
18	Immunohistochemical and Molecular Analysis of Human Melanomas for Expression of the Human Cancer-Testis Antigens NY-ESO-1 and LAGE-1 2004 ·Clinical Cancer Research ·Hilary Vaughan, Suzanne Svobodová, Duncan MacGregor, Sue Sturrock, Achim A. Jungbluth, Judy Browning, Ian D. Davis, (unknown), Yao‐Tseng Chen, Elisabeth Stockert, (unknown), Lloyd J. Old, Jonathan Cebon	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact